Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Protalix BioTherapeutics, Inc.
(NY:
PLX
)
5.180
USD
-0.020 (-0.38%)
Streaming Delayed Price
/ Updated:
10:09 AM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
3,723
Open
5.200
Bid (Size)
5.160 (200)
Ask (Size)
5.180 (600)
Prev. Close
5.200
Today's Range
5.170 - 5.240
52wk Range
4.710 - 6.800
Shares Outstanding
93,503,268
Dividend Yield
N/A
Top News
More News
Protalix BioTherapeutics Earnings In Retrospect: Down 1.9% in the Last 11 Days (PLX)
May 20, 2013
from
Comtex SmarTrend® News Briefs
Protalix BioTherapeutics to Present at the Oppenheimer 14th Annual Israeli Conference
May 08, 2013
from
GlobeNewswire News Releases
More News
Read More
Free Research Reports on GWAY, HNT, MDSO and PLX Issued by the Paragon Report
April 30, 2013
from
Marketwired News Releases
UPLYSO(TM) (alfataliglicerase) Approved in Mexico and Chile for the Treatment of Gaucher Disease
April 29, 2013
from
GlobeNewswire News Releases
Protalix Bio (PLX) Treats First Patient in PRX-112 Phase I
April 02, 2013
from
StreetInsider.com News Articles
Protalix BioTherapeutics Treats First Gaucher Patient in Phase I Study With PRX-112, an Orally-Administered Enzyme Treatment of Gaucher Disease
April 02, 2013
from
GlobeNewswire News Releases
Brazilian Approval a Positive for Protalix (PLX) - Oppenheimer
March 19, 2013
from
StreetInsider.com News Articles
U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous
March 19, 2013
from
Marketwired News Releases
UPDATE: Pfizer, Protalix Receive ANVISA Approval for UPLYSO in Brazil
March 18, 2013
category
Benzinga
,
PLX
,
News
, and 1 more.
from
Latest Articles from Benzinga.com
Pfizer (PFE), Protalix (PTX) UPLYSO Receives Approval in Brazil
March 18, 2013
from
StreetInsider.com News Articles
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.